Guerra Pan Advisors, LLC Invitae Corp Transaction History

Guerra Pan Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.6 - $1.53 $12 - $32	-21 Reduced 0.2%	10,335 $6.26 Million
Q1 2023 Apr 21, 2023	SELL	$1.2 - $2.73 $31 - $70	-26 Reduced 0.25%	10,356 $14 Million
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $401 - $848	-235 Reduced 2.21%	10,382 $19.3 Million
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $96 - $440	-51 Reduced 0.48%	10,617 $25,000
Q1 2022 May 11, 2022	SELL	$6.28 - $15.59 $6,060 - $15,044	-965 Reduced 8.3%	10,668 $54,000

Q4 2021 Feb 15, 2022	BUY	$14.7 - $28.67 $171,005 - $333,518	11,633 New	11,633 $178,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Guerra Pan Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Guerra Pan Advisors, LLC with notifications on news.